OIA
RPRX

OneDigital Investment Advisors’s Repros Therapeutics Inc. RPRX Stock Holding History

OneDigital Investment Advisors’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-16,400
Closed -$5K – 1315
2017
Q3 		$5K Buy
16,400
+10,000
+156% +$3.51K ﹤0.01% 903
2017
Q2 		$3K Buy
+6,400
New +$4.65K ﹤0.01% 1146

Other funds holding RPRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KAM
Kassirer Asset Management Toronto, Ontario, Canada $4.07M AUM 49.71% 1-Year Est. Return
AIA
Allegis Investment Advisors Idaho Falls, Idaho $326M AUM 10.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OneDigital Investment Advisors's RPRX Position: Q4 2017 in Review

OneDigital Investment Advisors sold out of Repros Therapeutics Inc. (RPRX) in Q4 2017, closing a stake of 16,400 shares — an estimated $5K sold.

OneDigital Investment Advisors first reported a position in RPRX in Q2 2017 and held it in 2 quarters. The position peaked at $5K in Q3 2017. 30 funds tracked by Wall St. Rank hold RPRX as of Q4 2017.

  • OneDigital Investment Advisors reported no remaining Repros Therapeutics Inc. position as of Q4 2017 after selling out during the quarter.
  • OneDigital Investment Advisors sold 16,400 Repros Therapeutics Inc. shares in Q4 2017, an estimated $5K.
  • OneDigital Investment Advisors first reported a position in Repros Therapeutics Inc. in Q2 2017 and held it in 2 quarters.
  • OneDigital Investment Advisors's Repros Therapeutics Inc. position peaked at $5K in Q3 2017.
  • 30 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q4 2017.

Based on OneDigital Investment Advisors's 13F filing for Q4 2017, filed 31 Jan 2018.